KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NVCT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Nuvectis Pharma, Inc. stock price ended at $6.51 on Thursday, after losing 2.98%.
(Updated on Apr 25, 2024)

Sell candidate since Apr 03, 2024 Loss -21.09% PDF

The Nuvectis Pharma, Inc. stock price fell by -2.98% on the last day (Thursday, 25th Apr 2024) from $6.71 to $6.51. During the last trading day the stock fluctuated 7.37% from a day low at $6.33 to a day high of $6.79. The price has fallen in 6 of the last 10 days and is down by -12.26% for this period. Volume has increased on the last day by 18 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 69 thousand shares were bought and sold for approximately $447.30 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $6.36 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -3.17% during the next 3 months and, with a 90% probability hold a price between $6.16 and $10.50 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NVCT Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has risen 1.56%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Nuvectis Pharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.74 and $8.21. A break-up above any of these levels will issue buy signals. Nuvectis Pharma, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Nuvectis Pharma, Inc. stock

Nuvectis Pharma, Inc. finds support from accumulated volume at $6.41 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.466 between high and low, or 7.37%. For the last week, the stock has had daily average volatility of 7.91%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NVCT) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Nuvectis Pharma, Inc. to open at $6.54, and during the day (based on 14 day Average True Range), to move between $5.82 and $7.20, which gives a possible trading interval of +/-$0.693 (+/-10.64%) up or down from last closing price. If Nuvectis Pharma, Inc. takes out the full calculated possible swing range there will be an estimated 21.28% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $6.41 (1.54%) than the resistance at $7.03 (7.99%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Nuvectis Pharma, Inc. stock A Buy?

Nuvectis Pharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.104 Sell Candidate Unchanged

Predicted Opening Price for Nuvectis Pharma, Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$6.54 ( 0.493%) $6.51

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NVCT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 7.01 7.65 %
R2 6.83 4.92 %
R1 6.72 3.23 %
Current price: 6.51
Support S1 6.36 -2.24 %
S2 6.25 -3.93 %
S3 6.08 -6.67 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 7.52 15.51 %
R2 7.46 14.59 %
R1 7.03 7.99 %
Current price 6.51
Support S1 6.41 -1.54%
S2 0 .
S3 0 .

FAQ

What is the symbol for Nuvectis Pharma, Inc. Stock and on which exchange is it traded?
The symbol for Nuvectis Pharma, Inc. is NVCT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Nuvectis Pharma, Inc. Stock?
Nuvectis Pharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Nuvectis Pharma, Inc. Stock?
Nuvectis Pharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Nuvectis Pharma, Inc. Stock.

What's the current price of Nuvectis Pharma, Inc. Stock?
As of the end of day on the Apr 25, 2024, the price of an Nuvectis Pharma, Inc. (NVCT) share was $6.51.

What is the 52-week high and low for Nuvectis Pharma, Inc. Stock?
The 52-week high for Nuvectis Pharma, Inc. Stock is $18.65 and the 52-week low is $6.21.

What is the market capitalization of Nuvectis Pharma, Inc. Stock?
As of the Apr 25, 2024, the market capitalization of Nuvectis Pharma, Inc. is 115.675M.

When is the next earnings date for Nuvectis Pharma, Inc.?
The upcoming earnings date for Nuvectis Pharma, Inc. is May 08, 2024.
Click to get the best stock tips daily for free!

About Nuvectis Pharma, Inc.

Nuvectis Pharma. Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.... NVCT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT